Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02675829
Brief Title: Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers

First Submitted : February 3, 2016
First Submitted that Met QC Criteria : February 3, 2016
First Posted : February 5, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : March 13, 2019
Last Update Posted : March 14, 2019